| (USD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 95.02M | 7.76% |
| Operating expense | — | — |
| Net income | 36.17M | 1.50% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CLVLF returned -4.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -1.3% |
| 1 year | -4.5% |
| 5 years | -72.1% |
| 10 years | +93.3% |
| All-time high | $30.90 (Sep 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CLVLF would be worth today ›No. Clinuvel Pharmaceuticals Limited has not paid a dividend in the past 12 months.
Clinuvel Pharmaceuticals Limited is part of the Healthcare sector.
Clinuvel Pharmaceuticals Limited has a market cap of 398.63M USD, based on the latest quote.
Clinuvel Pharmaceuticals Limited is scheduled to report earnings on Aug 27, 2026.
